Next Article in Journal
Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
Next Article in Special Issue
Comparative Evaluation of Intestinal Absorption and Functional Value of Iron Dietary Supplements and Drug with Different Delivery Systems
Previous Article in Journal
In Vitro Evaluation of Lipopolyplexes for Gene Transfection: Comparing 2D, 3D and Microdroplet-Enabled Cell Culture
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes

by
Marina Piscopo
1,*,†,
Rosaria Notariale
2,†,
Fabiana Tortora
2,
Gennaro Lettieri
1,
Giancarlo Palumbo
3 and
Caterina Manna
2,*
1
Department of Biology, University of Naples Federico II, 80126 Naples, Italy
2
Department of Precision Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, via Luigi de Crecchio, 80138 Naples, Italy
3
Department of Economics, Management, Institutions, University of Naples Federico II, via Cupa Nuova Cinthia, 80126 Naples, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2020, 25(14), 3278; https://doi.org/10.3390/molecules25143278
Submission received: 12 June 2020 / Revised: 16 July 2020 / Accepted: 18 July 2020 / Published: 19 July 2020

Abstract

:
Mercury (Hg) is a global environmental pollutant that affects human and ecosystem health. With the aim of exploring the Hg-induced protein modifications, intact human erythrocytes were exposed to HgCl2 (1–60 µM) and cytosolic and membrane proteins were analyzed by SDS-PAGE and AU-PAGE. A spectrofluorimetric assay for quantification of Reactive Oxygen Species (ROS) generation was also performed. Hg2+ exposure induces alterations in the electrophoretic profile of cytosolic proteins with a significant decrease in the intensity of the hemoglobin monomer, associated with the appearance of a 64 kDa band, identified as a mercurized tetrameric form. This protein decreases with increasing HgCl2 concentrations and Hg-induced ROS formation. Moreover, it appears resistant to urea denaturation and it is only partially dissociated by exposure to dithiothreitol, likely due to additional protein–Hg interactions involved in aggregate formation. In addition, specific membrane proteins, including band 3 and cytoskeletal proteins 4.1 and 4.2, are affected by Hg2+-treatment. The findings reported provide new insights into the Hg-induced possible detrimental effects on erythrocyte physiology, mainly related to alterations in the oxygen binding capacity of hemoglobin as well as decreases in band 3-mediated anion exchange. Finally, modifications of cytoskeletal proteins 4.1 and 4.2 could contribute to the previously reported alteration in cell morphology.

1. Introduction

Human exposure to heavy metals has increased significantly in the last decades as a result of a parallel increment in the use of these metals in industrial processes [1] and products [2,3]. Therefore, considerable attention has been focused on environmental pollution and the biological effects of these elements [4,5], including mercury (Hg) [6]. Hg contamination is extensive in all environmental compartments such as soil, air and water [7,8] and human exposure to Hg has increased with modern industrialization due to its anthropogenic emissions from fuel combustion, municipal incinerators and chemical industries. The pathways of Hg exposure in the general population mainly include respiration and the ingestion of food [9].
The health consequences of such exposure can be severe, leading to adverse health outcomes [10,11,12,13]. Renal damage [14,15] and neuronal disorders [16,17] are well characterized toxic effects of Hg. The contribution of environmental pollutants, including Hg, to the etiology of autism spectrum disorder has been recently reviewed [18]. In addition, prolonged Hg exposure is considered as a contributing risk factor for Cardiovascular Disease [19,20]. In this respect, a recent meta-analysis indicates a significant positive association between high Hg body burden and hypertension, likely due to both endothelial and renal dysfunction [21]. Furthermore, Wierzbicki et al. [22] reported that workers occupationally exposed to mercuric vapors exhibited a statistically significant increase in blood coagulation along with increased thrombin generation. Interestingly, in vitro exposure of intact red blood cell (RBC) to mercuric chloride (HgCl2) induces morphological changes [23], which increase their pro-coagulant activity [24]. RBC are indeed an important target of Hg toxicity because this metal preferentially accumulates in these cells [25]. The literature data on the mechanisms involved in the transport of mercuric ions in target tissue have recently been reviewed by Bridges and Zalups [26]. As far as mercury uptake by RBC is concerned, the majority of the data refers to organic forms of mercury, indicating that when rats are injected with a nonnephrotoxic dose of methyl mercury, approximately 30% of the administered dose is detected in blood after 24 h and 99% of blood Hg is associated with RBC [27]. The study of HgCl2 uptake by RBC has been addressed by a few old papers, which report that RBC uptake of HgCl2 is rapid and reaches equilibrium concentration in a few minutes [28].
Heavy metals taken into the organism can exert their toxic effects through different mechanisms [29,30]. As far as Hg toxicity is concerned, it is endowed with a high affinity for sulphydryl groups; therefore this metal is able to react with small molecular-weight (MW) thiols, including glutathione (GSH), thus impairing the antioxidant defence system [31,32]. In addition, by reacting with crucial cysteine (Cys) residues, Hg may interact with cellular proteins, thus altering and inhibiting their enzymatic and structural functions and potentially leading to severe dysfunction in cellular activities [33]. In particular, Hg inhibitory activity on individual glycolytic enzymes, such as hexokinase and phosphofructokinase, has been reported [34]. Important mitochondrial functions are also affected by Hg, such as the activity of F1-F0-ATPase [35]. Furthermore, carnitine/acylcarnitine transporter has been identified as a possible target of Hg toxicity [36].
To further investigate Hg-induced cytotoxicity at the molecular level, the possible interaction of this heavy metal with RBC proteins was studied, using a cellular model system. In this paper, we offer experimental evidence that both hemoglobin (Hb) as well as specific membrane proteins can be altered by HgCl2 treatment, as revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Acetic Acid Urea-Polyacrylamide Gel Electrophoresis (AU-PAGE). To the best of our knowledge, no studies have been published using this experimental approach. A discussion on the possible Hg2+–protein chemical interactions and correlation between reactive oxygen species (ROS) production and Hb aggregation state is also provided.

2. Results

In order to explore the possible interaction of Hg with erythrocyte proteins, intact human RBC were exposed for 4 h in vitro to increasing HgCl2 concentrations (1–60 µM) and the electrophoretic profiles of both cytosolic and membrane proteins were evaluated. In our previous studies, exploring the dose-dependency of Hg toxic effects on RBC, this HgCl2 concentration range was found to be optimal in order to study the oxidative stress (OS)-mediated cytotoxicity in these cells [37,38,39]

2.1. Electrophoretic Analyses of Cytosolic Proteins from Hg-Exposed Human RBC

As shown in Figure 1A (lane 2), the SDS-PAGE of the cytosolic fraction from control cells reveals the presence of a main band, identified as the Hb monomer according to its MW. Exposure of cells to all tested HgCl2 concentrations results in a significant alteration in the electrophoretic profile of the cytosolic proteins, with the appearance of additional protein bands with reduced mobility compared to the Hb monomer, likely indicating the formation of aggregates.
Among them, the most representative reduced mobility protein band, showing an apparent MW of 64 kDa, might represent a tetrameric form of Hb. Accordingly, the densitometric analysis of the two main protein bands (16 and 64 kDa), shown in Figure 1B, clearly indicated that, following the treatment of RBC with HgCl2, the 64 kDa protein band is formed at the expense of the Hb monomer. In addition, it is worth noting that the intensity of the 64 kDa protein band is maximum in samples from cells exposed to 1 µM, while it decreases with increasing HgCl2 concentrations.
The formation of the Hg-induced protein aggregates was also confirmed by AU-PAGE analysis of samples obtained from cells exposed to 1, 10 and 60 µM HgCl2, also indicating that these Hg-induced protein aggregates are resistant to urea denaturation (Figure 2).

2.2. Effect of Dithiothreitol on Hg-Induced Protein Aggregate Formation in Human RBC

In order to investigate the possible involvement of sulfhydryl groups in the formation of protein aggregates in Hg2+-exposed cells, the effect of Dithiothreitol (DTT) was tested, adding the reduced agent either prior or subsequent to cell treatment with HgCl2. The analysis by SDS-PAGE of the cytosolic fraction of RBC exposed to 1 µM HgCl2, followed by DTT treatment for 30 min, reveals a significant decrease in the intensity of the band corresponding to tetrameric Hb, associated with a parallel increase in the Hb monomer, as shown in Figure 3A (lane 6). This finding indicates that DTT treatment causes a partial dissociation of the aggregates, probably reducing sulphur-related bonds. Interestingly, longer DTT cell treatment (60 and 120 min) does not result in the complete disappearance of the 64 kDa protein band (data not shown), likely due to additional protein–Hg interactions involved in protein aggregate formation. Conversely, RBC pre-treatment with DTT, followed by cell exposure to HgCl2, prevents the Hg2+-induced modification of the electrophoretic profile completely. In this experimental condition, indeed, we can hypothesize that DTT may react rapidly and directly with the heavy metal, thus interfering with the interactions between Hg2+ and protein.

2.3. Electrophoretic Analyses of Membrane Proteins from Hg-Exposed Human RBC

On the basis of these results, we use 1 µM HgCl2 to evaluate the effect of this heavy metal on the erythrocyte membrane proteins. The cellular membrane is a major target of Hg damage in RBC, particularly related to phosphatidylserine translocation to the cellular surface, which implies loss of membrane asymmetry [40]. Moreover, in our previous paper, an overall decrease in erythrocyte membrane protein thiols has been reported [23]. Therefore, with the aim to identify the specific Hg2+-modified erythrocyte membrane proteins, alterations in the electrophoretic profile of the membrane fraction from Hg2+-exposed RBC was analysed by SDS-PAGE. The typical electrophoretic profile of RBC membrane proteins is shown in Figure 4. The Hg2+ treatment of RBC results in the appearance of an additional protein band of apparent MW of about 40 kDa, undetectable in the control RBC. Moreover, in Hg2+-treated samples, difference in the protein band ratios is evident. In particular, an increase in the intensity of bands 3, 4.1, 4.2 and a decrease in the intensity of the band corresponding to glyceraldehyde-3-phosphate-dehydrogenase are observable.

2.4. Effect of Hg on ROS Formation in Human RBC

In order to investigate the possible role of the OS in the Hg-induced erythrocyte protein modifications, the Dichlorofluorescein (DCF) fluorescent assay was performed to measure ROS formation. As shown in Figure 5, in our experimental conditions, RBC incubation in the presence of 1–60 µM HgCl2 results in an increase in DCF fluorescent signal, thus indicating a dose-dependent ROS formation, starting from RBC samples exposed to 40 µM HgCl2. This finding suggests that HgCl2 treatment determines the exposition of RBC to an oxidative microenvironment only at the higher metal concentrations. Interestingly, no Hg2+-induced ROS formation occurs in the concentration range 1–20 µM, in which the maximum effect of Hg2+ on protein aggregation is observable.

3. Discussion

In recent decades, heavy metals—widespread environmental pollutants—received considerable scientific attention because their potential health and environmental risks [1,2,41]. The toxic biological effects of human exposure to these metals are extremely numerous. Among the molecular mechanisms underlying their toxicity, protein interactions seem to play a key role, possibly leading to structural and functional alterations, thus interfering with important metabolic as well as regulatory cellular function [33,42,43,44].
Here, we report data on the Hg2+-induced RBC protein alterations, as revealed by the electrophoretic analysis of both cytosolic as well as membrane fractions. Blood represents a major target of toxicants that enter the body through any route and RBC are particularly vulnerable to their harmful effects [25], being a preferential store for toxic heavy metals. In particular, Hg accumulates in these cells, mainly bound to the SH group of the cellular thiol GSH, present in very high concentrations in these cells [45].
In this study, we exposed intact human RBC to HgCl2 in vitro in the range of 1–60 μM and we demonstrated that this treatment induces significant alterations in the electrophoretic behaviour of both Hb and membrane proteins. As far as the Hg–Hb interaction is concerned, the presence of protein bands with reduced mobility compared to that corresponding to the Hb monomer was observed throughout the range of concentrations utilized. In particular, a protein band likely corresponding to a Hb tetramer on the basis of its apparent MW was observable. These data are in agreement with the reported Hg-induced protein coagulation effect on purified bovine Hb, incubated in vitro in the presence of mercuric acetate [46]. At this stage of investigation, we do not provide direct evidence of increased or decreased oxygen affinity for mercurized-Hb. However, if we assume that the Hg binding sites [46] should be likely located at or near the dimer–dimer contact interface, we would expect rather strong Hg-induced alterations in Hb monomers interactions, affecting the physiological cooperative conformational changes necessary for the oxygenation/deoxygenation process. Furthermore, the possibility that such Hg-induced perturbations would lead to the autooxidation of the ferrous iron of the heme to form methemoglobin can not be ruled out, resulting in the loss of ability to bind oxygen. Particularly interesting is the finding that Hg2+-induced Hb polymer formation is observed starting from a concentration as low as 1 μM. It is interesting to note, in this respect, that similar Hg concentrations have been found in the blood of individuals exposed to specific working environments, such as gold mines, as well as in people living in the surrounding areas [47]. Furthermore, workers occupationally exposed to Hg vapor show increased Hg blood concentration up to 0.4 µM, associated with significant alteration in the coagulation system [22]. Finally, in a recent paper, Forte et al. [48] reported abnormally high blood Hg levels in people living close to contaminated areas in Southern Italy. Increased Hg blood level is also strongly related to contaminated fish consumption [49].
An unexpected figure in the reported findings is that the amount of “mercurized” tetrameric Hb form decreases with increasing HgCl2 concentrations. A possible explanation of the inversely proportional dose-dependence of the Hg2+-induced polymer formation is that it may be related to OS. This element is a powerful but indirect inducer of OS in biological systems, as reported in our previous studies, in which the experimental evidence indicates that Hg2+-induced ROS generation is a late event in RBC, subsequent to a significant decrease in GSH [40]. This has recently been confirmed, in similar experimental conditions, by Ahmad and Mahmood [25] also for reactive nitrogen species formation. Therefore, increased OS may cause, at the higher concentrations utilized in our study, alterations in Hb aminoacidic residues incompatible or less compatible with the tetrameric form.
Concerning the possible specific amino acid residues that are able to interact with Hg2+, our data on the significant reduction in the tetrameric form upon incubation of the Hg2+-treated RBC with the reducing agent DTT allow us to hypothesize that accessible Cys residues represent the preferential site of Hg–protein interaction. It is worth noting, in this respect, that two critical Cys in position 93 of the beta-chains have been identified as nitric oxide (NO) ligand, playing a role in Hb-mediated NO release [50]. Thus, the alteration of Cys-93, following Hg2+ interaction, might impair the Hb-mediated regulation of blood flow, therefore representing one of the physiologically important manifestations of Hg poisoning in these cells. Additional Hg-binding sites cannot be excluded, likely enhancing the aggregation process, including histidine residues. In this respect, the Hg-induced chymotrypsin aggregate formation is reported to be mediated by Hg2+–histidine interaction [51].
In addition, the effect of Hg2+ on RBC membrane proteins was also evaluated. A significant depletion in the overall membrane thiols has been reported in our previous paper, in similar experimental conditions [23]. The SDS-PAGE analysis revealed that cell treatment with HgCl2 results in alterations in the membrane protein electrophoretic profile, particularly related to bands 3, 4.1 and 4.2. Band 3 protein (B3p) is the most abundant integral protein on the RBC membrane, endowed with specific anion exchange capabilities, being responsible for acid balance, ion distribution and gas exchange [52,53]. Furthermore, it is also involved in RBC mechanical and osmotic properties, such as maintenance of biconcave cell shape and deformability. In particular, B3p is involved in specific protein–protein interactions, by connecting plasma membrane to the underlying cytoskeleton, through SH groups of specific Cys residues [53]. In this respect, Cys-201 and/or Cys-317, located at the cytoplasmic domain of B3p, are critical for ankyrin binding [54]. Accordingly, their derivatization with thiol reagents are reported to block ankyrin interaction and a specific antibody raised against a synthetic peptide containing Cys-201 acts as a potent inhibitor of ankyrin binding [55]. Moreover, band 4.1 and 4.2 proteins, key components of the cytoskeleton network [56], also contain accessible cysteines [57,58]. In conclusion, a large body of literature, accumulated over several years by our group and others, clearly demonstrates the RBC structural and metabolic alterations induced by Hg, indicating severe alterations in the physiology and morphology of these cells. Among these, exposure of phosphatidylserine at the level of the membrane is the most serious and most studied [40]. Taken together, the findings reported in this paper provide new insight in the Hg-induced alterations in human RBC using a cellular model system on hemoglobin and membrane proteins. Concerning the latter, our work represents the first study revealing alterations of specific membrane proteins, including those of the cytoskeleton, partially responsible for the morphological changes that are reported in our previous studies, consequent to exposure of intact cells in the presence of HgCl2 [23]. In particular, the observed structural modification to band 3 could suggest an alteration in the RBC anionic exchange capability that deserves further investigations.

4. Materials and Methods

4.1. Preparation of RBC and HgCl2 Treatment

Whole blood was taken by venipuncture from healthy volunteers, collected in heparinized tubes and centrifuged at 1200× g for 15 min at 4 °C. After removal of the buffy coat, the RBC fraction was washed twice with isotonic saline solution (0.9% NaCl) and resuspended in Krebs buffer (NaCl 7.305 g/L; KCl 0.79 g/L; MgSO4 0.29 g/L; Hepes 7.69 g/L; CaCl2 0.11 g/L; NaOH 0.54 g/L, containing 2.8 mM glucose) to obtain a 10% (v/v) hematocrit. Hg treatment was performed by incubation of aliquots of the cell suspension at 37 °C for 4 h, in the presence of different concentrations of HgCl2 in the range of 1–60 µM. A stock solution of HgCl2 was diluted in Krebs buffer.

4.2. Dithiothreitol (DTT) Treatment

The effect of DTT was tested by adding the reduced agent, at a final concentration of 30 mM, 30 min prior or subsequent to RBC incubation for 4 h with 1 µM HgCl2. Cell treatment with DTT after HgCl2 incubation was also repeated at 60 and 120 min.

4.3. Preparation of Erythrocyte Membranes

The erythrocyte membrane fractions were prepared according to Galletti et al. [59], with minor modifications. After Hg2+ treatment, the samples were centrifuged and the hemolysis was performed by rapidly mixing packed RBC with 40 volumes of 5 mM sodium phosphate, pH 8.8. The membrane pellets, obtained by centrifugation at 27,000× g for 30 min at 4 °C, were then washed several times with the lysis buffer to remove unspecifically bound Hb. Creamy white ghosts were resuspended in 0.2% SDS and incubated for 30 min at 37 °C, prior to being used for the electrophoretic analysis.

4.4. Electrophoretic Analyses

SDS-PAGE for cytosolic fraction proteins was performed as previously described in Vassalli et al. [60]. For membrane proteins, a stacking gel at 4.0% (w/v) acrylamide (acrylamide/bis-acrylamide 25:0.67) and a separating gel at 12.0% (w/v) acrylamide (acrylamide/bis-acrylamide 25:0.67) was utilized. At the end of the run, the gels were stained with Coomassie Brilliant Blue and acquired using a GelDoc system via Quantity One v.4.4.0 software (BioRad, Hercules, CA, USA). The densitometric analysis of gel bands was carried out using the software ImageJ.
AU-PAGE was performed as previously described in Fioretti et al. [61] with modifications reported in Piscopo et al. [62]. Protein samples were run on polyacrylamide gels prepared at 9% (w/v) acrylamide (acrylamide:bisacrylamide 25:0.67). The gels were stained with Amido Black.

4.5. Determination of Reactive Oxygen Species (ROS)

Dichlorofluorescein (DCF) assay was performed to detect ROS generation, according to Tagliafierro et al. Intact RBC were incubated with the nonpolar, non-fluorescent 2′,7′-dichlorodihydrofluorescin diacetate (DCFH-DA, Sigma-Aldrich, St. Louis, MO, USA), at a final concentration of 10 μM for 15 min at 37 °C. After centrifugation of cellular suspension at 1200× g for 5 min, the supernatant was removed, and the hematocrit was adjusted to 10% with Krebs, and RBC were treated with the selected HgCl2 concentrations in the dark for 4 h at 37 °C. At the end of the treatment, 20 μL of RBC suspension was diluted in 2 mL of distilled water and the fluorescent intensity of the oxidative derivative DCF was recorded (λexc 502; λem 520). The results were expressed as fluorescent intensity/mg Hb.

4.6. Protein Determination

Protein concentration was determined by the method of Bradford [63], using bovine serum albumin as standard.

4.7. Statistical Analyses

Images in figures are representative of 4–6 independent experiments performed with RBC of different donors. Data of ROS evaluation were expressed as means ± S.E.M of 3 independent experiments performed with different donors. The significance of differences was determined by one-way ANOVA followed by a post hoc Dunnett’s multiple comparisons test, using p < 0.05 as the criterion of significance. GraphPad Prism 8 was utilized for statistical analysis.

Author Contributions

Conceptualization, M.P. and C.M.; methodology, R.N., F.T. and G.L.; software, G.L.; validation, M.P., C.M. and G.P.; formal analysis, M.P., C.M. and G.P.; investigation, R.N., F.T. and G.L.; writing—original draft preparation, M.P., C.M. and G.P.; visualization, G.L. and R.N.; supervision, M.P. and C.M.; project administration, M.P. and C.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We thank Janet Gates d’Amato for providing the English revision of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yousaf, B.; Amina; Liu, G.; Wang, R.; Imtiaz, M.; Rizwan, M.S.; Zia-Ur-Rehman, M.; Qadir, A.; Si, Y. The importance of evaluating metal exposure and predicting human health risks in urban-periurban environments influenced by emerging industry. Chemosphere 2016, 150, 79–89. [Google Scholar] [CrossRef]
  2. Maresca, V.; Fusaro, L.; Sorbo, S.; Siciliano, A.; Loppi, S.; Paoli, L.; Monaci, F.; Karam, E.A.; Piscopo, M.; Guida, M.; et al. Functional and structural biomarkers to monitor heavy metal pollution of one of the most contaminated freshwater sites in Southern Europe. Ecotox. Environ. Saf. 2018, 163, 665–673. [Google Scholar] [CrossRef]
  3. Basile, A.; Loppi, S.; Piscopo, M.; Paoli, L.; Vannini, A.; Monaci, F.; Sorbo, S.; Lentini, M.; Esposito, S. The biological response chain to pollution: A case study from the “Italian Triangle of Death” assessed with the liverwort Lunularia cruciata. Environ. Sci. Pollut. Res. Int. 2017, 24, 26185–26193. [Google Scholar] [CrossRef]
  4. Rehman, K.; Fatima, F.; Waheed, I.; Akash, M.S.H. Prevalence of exposure of heavy metals and their impact on health consequences. J. Cell Biochem. 2018, 119, 157–184. [Google Scholar] [CrossRef]
  5. Paschoalini, A.L.; Savassi, L.A.; Arantes, F.P.; Rizzo, E.; Bazzoli, N. Heavy metals accumulation and endocrine disruption in Prochilodus argenteus from a polluted neotropical river. Ecotox. Environ. Saf. 2019, 169, 539–550. [Google Scholar] [CrossRef]
  6. Spiegel, S.J. New mercury pollution threats: A global health caution. Lancet 2017, 390, 226–227. [Google Scholar] [CrossRef] [Green Version]
  7. Branco, V.; Caito, S.; Farina, M.; Teixeira da Rocha, J.; Aschner, M.; Carvalho, C. Biomarkers of mercury toxicity: Past, present, and future trends. J. Toxicol. Environ. Health B Crit. Rev. 2017, 20, 119–154. [Google Scholar] [CrossRef] [PubMed]
  8. Driscoll, C.T.; Mason, R.P.; Chan, H.M.; Jacob, D.J.; Pirrone, N. Mercury as a Global Pollutant: Sources, Pathways, and Effects. Environ. Sci. Tecnol. 2013, 47, 4967–4983. [Google Scholar] [CrossRef] [PubMed]
  9. Okpala, C.O.R.; Sardo, G.; Vitale, S.; Bono, G.; Arukwe, A. Hazardous properties and toxicological update of mercury: From fish food to human health safety perspective. Crit. Rev. Food Sci. Nutr. 2018, 58, 1986–2001. [Google Scholar] [CrossRef] [PubMed]
  10. Silbergeld, E.K.; Silva, I.A.; Nyland, J.F. Mercury and autoimmunity: Implications for occupational and environmental health. Toxicol. Appl. Pharmacol. 2005, 207, 282–292. [Google Scholar] [CrossRef] [PubMed]
  11. Sundseth, K.; Pacyna, J.M.; Pacyna, E.G.; Pirrone, N.; Thorne, R.J. Global Sources and Pathways of Mercury in the Context of Human Health. Int. J. Environ. Res. Public Health 2017, 14, 105. [Google Scholar] [CrossRef] [PubMed]
  12. Tinkov, A.A.; Ajsuvakova, O.P.; Skalnaya, M.G.; Popova, E.V.; Sinitskii, A.I.; Nemereshina, O.N.; Gatiatulina, E.R.; Nikonorov, A.A.; Skalny, A.V. Mercury and metabolic syndrome: A review of experimental and clinical observations. Biometals 2015, 28, 231–254. [Google Scholar] [CrossRef] [PubMed]
  13. Rice, K.M.; Walker, E.M.; Wu, M.; Gillette, C.; Blough, E.R. Environmental Mercury and Its Toxic Effects. J. Prev. Med. Public Health 2014, 47, 74–83. [Google Scholar] [CrossRef] [PubMed]
  14. Miller, S.; Pallan, S.; Gangji, A.S.; Lukic, D.; Clase, C.M. Mercury-associated nephrotic syndrome: A case report and systematic review of the literature. Am. J. Kidney Dis. 2013, 62, 135–138. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Zalups, R.K. Molecular interactions with mercury in the kidney. Pharmacol. Rev. 2000, 52, 113–143. [Google Scholar]
  16. Andrew, A.S.; Chen, C.Y.; Caller, T.A.; Tandan, R.; Henegan, P.L.; Jackson, B.P.; Hall, B.P.; Bradley, W.G.; Stommel, E.W. Toenail mercury levels are associated with amyotrophic lateral sclerosis (ALS) risk. Muscle Nerve 2018. [Google Scholar] [CrossRef]
  17. Carocci, A.; Rovito, N.; Sinicropi, M.S.; Genchi, G. Mercury toxicity and neurodegenerative effects. Rev. Environ. Contam. Toxicol. 2014, 229, 1–18. [Google Scholar] [CrossRef]
  18. Bölte, S.; Girdler, S.; Marschik, P.B. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol. Life Sci. 2019, 76, 1275–1297. [Google Scholar] [CrossRef] [Green Version]
  19. Houston, M.C. The Role of Mercury in Cardiovascular Disease. J. Cardiovasc. Dis. Diagn. 2014, 2, 1–8. [Google Scholar] [CrossRef]
  20. Genchi, G.; Sinicropi, M.S.; Carocci, A.; Lauria, G.; Catalano, A. Mercury Exposure and Heart Diseases. Int. J. Environ. Res. Public Health 2017, 14, 74. [Google Scholar] [CrossRef] [Green Version]
  21. Hu, X.F.; Singh, K.; Chan, H.M. Mercury Exposure, Blood Pressure, and Hypertension: A Systematic Review and Dose-response Meta-analysis. Environ. Health Perspect. 2018, 126, 076002. [Google Scholar] [CrossRef] [PubMed]
  22. Wierzbicki, R.; Prażanowski, M.; Michalska, M.; Krajewska, U.; Mielicki, W.P. Disorders in blood coagulation in humans occupationally exposed to mercuric vapors. J. Trace Elem. Exp. Med. 2002, 15, 21–29. [Google Scholar] [CrossRef]
  23. Tortora, F.; Notariale, R.; Maresca, V.; Good, K.V.; Sorbo, S.; Basile, A.; Piscopo, M.; Manna, C. Phenol-Rich Feijoa sellowiana (Pineapple Guava) Extracts Protect Human Red Blood Cells from Mercury-Induced Cellular Toxicity. Antioxidants 2019, 8, 220. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Lim, K.-M.; Kim, S.; Noh, J.-Y.; Kim, K.; Jang, W.-H.; Bae, O.-N.; Chung, S.-M.; Chung, J.-H. Low-level mercury can enhance procoagulant activity of erythrocytes: A new contributing factor for mercury-related thrombotic disease. Environ. Health Perspect. 2010, 118, 928–935. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Ahmad, S.; Mahmood, R. Mercury chloride toxicity in human erythrocytes: Enhanced generation of ROS and RNS, hemoglobin oxidation, impaired antioxidant power, and inhibition of plasma membrane redox system. Environ. Sci. Pollut. Res. Int. 2019, 26, 5645–5657. [Google Scholar] [CrossRef] [PubMed]
  26. Bridges, C.C.; Zalups, R.K. Mechanisms involved in the transport of mercuric ions in target tissues. Arch. Toxicol. 2017, 91, 63–81. [Google Scholar] [CrossRef] [Green Version]
  27. Zalups, R.K.; Bridges, C.C. MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA. Toxicol. Appl. Pharmacol. 2009, 235, 10–17. [Google Scholar] [CrossRef]
  28. Rabenstein, D.L.; Isab, A.A. A proton nuclear magnetic resonance study of the interaction of mercury with intact human erythrocytes. Biochim. Biophys. Acta 1982, 721, 374–384. [Google Scholar] [CrossRef]
  29. Wu, X.; Cobbina, S.J.; Mao, G.; Xu, H.; Zhang, Z.; Yang, L. A review of toxicity and mechanisms of individual and mixtures of heavy metals in the environment. Environ. Sci. Pollut. Res. Int. 2016, 23, 8244–8259. [Google Scholar] [CrossRef]
  30. Ricchelli, F.; Drago, D.; Filippi, B.; Tognon, G.; Zatta, P. Aluminum-triggered structural modifications and aggregation of beta-amyloids. Cell. Mol. Life Sci. 2005, 62, 1724–1733. [Google Scholar] [CrossRef]
  31. Hernández, L.E.; Sobrino-Plata, J.; Montero-Palmero, M.B.; Carrasco-Gil, S.; Flores-Cáceres, M.L.; Ortega-Villasante, C.; Escobar, C. Contribution of glutathione to the control of cellular redox homeostasis under toxic metal and metalloid stress. J. Exp. Bot. 2015, 66, 2901–2911. [Google Scholar] [CrossRef] [Green Version]
  32. Rooney, J.P.K. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 2007, 234, 145–156. [Google Scholar] [CrossRef] [PubMed]
  33. Ynalvez, R.; Gutierrez, J.; Gonzalez-Cantu, H. Mini-review: Toxicity of mercury as a consequence of enzyme alteration. Biometals 2016, 29, 781–788. [Google Scholar] [CrossRef]
  34. Ramírez-Bajo, M.J.; de Atauri, P.; Ortega, F.; Westerhoff, H.V.; Gelpí, J.L.; Centelles, J.J.; Cascante, M. Effects of Cadmium and Mercury on the Upper Part of Skeletal Muscle Glycolysis in Mice. PLoS ONE 2014, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Nesci, S.; Trombetti, F.; Pirini, M.; Ventrella, V.; Pagliarani, A. Mercury and protein thiols: Stimulation of mitochondrial F1FO-ATPase and inhibition of respiration. Chem. Biol. Interact. 2016, 260, 42–49. [Google Scholar] [CrossRef] [PubMed]
  36. Tonazzi, A.; Giangregorio, N.; Console, L.; Scalise, M.; La Russa, D.; Notaristefano, C.; Brunelli, E.; Barca, D.; Indiveri, C. Mitochondrial carnitine/acylcarnitine transporter, a novel target of mercury toxicity. Chem. Res. Toxicol. 2015, 28, 1015–1022. [Google Scholar] [CrossRef] [PubMed]
  37. Tagliafierro, L.; Officioso, A.; Sorbo, S.; Basile, A.; Manna, C. The protective role of olive oil hydroxytyrosol against oxidative alterations induced by mercury in human erythrocytes. Food Chem. Toxicol. 2015, 82, 59–63. [Google Scholar] [CrossRef]
  38. Officioso, A.; Panzella, L.; Tortora, F.; Alfieri, M.L.; Napolitano, A.; Manna, C. Comparative Analysis of the Effects of Olive Oil Hydroxytyrosol and Its 5-S-Lipoyl Conjugate in Protecting Human Erythrocytes from Mercury Toxicity. Oxid. Med. Cell Longev. 2018, 2018, 9042192. [Google Scholar] [CrossRef] [Green Version]
  39. Officioso, A.; Alzoubi, K.; Lang, F.; Manna, C. Hydroxytyrosol inhibits phosphatidylserine exposure and suicidal death induced by mercury in human erythrocytes: Possible involvement of the glutathione pathway. Food Chem. Toxicol. 2016, 89, 47–53. [Google Scholar] [CrossRef]
  40. Eisele, K.; Lang, P.A.; Kempe, D.S.; Klarl, B.A.; Niemöller, O.; Wieder, T.; Huber, S.M.; Duranton, C.; Lang, F. Stimulation of erythrocyte phosphatidylserine exposure by mercury ions. Toxicol. Appl. Pharmacol. 2006, 210, 116–122. [Google Scholar] [CrossRef]
  41. Piscopo, M.; Ricciardiello, M.; Palumbo, G.; Troisi, J. Selectivity of metal bioaccumulation and its relationship with glutathione S-transferase levels in gonadal and gill tissues of Mytilus galloprovincialis exposed to Ni (II), Cu (II) and Cd (II). Rend. Fis. Acc. Lincei. 2016, 27, 737–748. [Google Scholar] [CrossRef] [Green Version]
  42. Piscopo, M.; Trifuoggi, M.; Scarano, C.; Gori, C.; Giarra, A.; Febbraio, F. Relevance of arginine residues in Cu(II)-induced DNA breakage and Proteinase K resistance of H1 histones. Sci. Rep. 2018, 8, 1–10. [Google Scholar] [CrossRef] [Green Version]
  43. Lettieri, G.; Mollo, V.; Ambrosino, A.; Caccavale, F.; Troisi, J.; Febbraio, F.; Piscopo, M. Molecular effects of copper on the reproductive system of mytilus galloprovincialis. Mol. Reprod. Devel. 2019, 86, 1357–1368. [Google Scholar] [CrossRef] [PubMed]
  44. Piscopo, M.; Notariale, R.; Rabbito, D.; Ausió, J.; Olanrewaju, O.S.; Guerriero, G. Mytilus galloprovincialis (Lamarck, 1819) spermatozoa: hsp70 expression and protamine-like protein property studies. Environ. Sci. Pollut. Res. 2018, 25, 12957–12966. [Google Scholar] [CrossRef] [PubMed]
  45. Prchal, J.T.; Castleberry, R.P.; Parmley, R.T.; Crist, W.M.; Malluh, A. Hereditary Pyropoikilocytosis and Elliptocytosis: Clinical, Laboratory, and Ultrastructural Features in Infants and Children. Pediatr. Res. 1982, 16, 484–489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Myshkin, A.E.; Khromova, V.S. A new insight into mercurized hemoglobin aggregation mechanism. Biochim. Biophys. Acta 2005, 1749, 1–6. [Google Scholar] [CrossRef] [PubMed]
  47. Akagi, H.; Malm, O.; Branches, F.J.P.; Kinjo, Y.; Kashima, Y.; Guimaraes, J.R.D.; Oliveira, R.B.; Haraguchi, K.; Pfeiffer, W.C.; Takizawa, Y.; et al. Human Exposure to Mercury Due to Goldmining in the Tapajos River Basin, Amazon, Brazil: Speciation of Mercury in Human Hair, Blood and Urine. Water Air Soil Pollut. 1995, 80, 85–94. [Google Scholar] [CrossRef]
  48. Forte, I.M.; Indovina, P.; Costa, A.; Iannuzzi, C.A.; Costanzo, L.; Marfella, A.; Montagnaro, S.; Botti, G.; Bucci, E.; Giordano, A. Blood screening for heavy metals and organic pollutants in cancer patients exposed to toxic waste in southern Italy: A pilot study. J. Cell Physiol. 2020, 235, 5213–5222. [Google Scholar] [CrossRef]
  49. McKelvey, W.; Gwynn, R.C.; Jeffery, N.; Kass, D.; Thorpe, L.E.; Garg, R.K.; Palmer, C.D.; Parsons, P.J. A Biomonitoring Study of Lead, Cadmium, and Mercury in the Blood of New York City Adults. Environ. Health Perspect. 2007, 115, 1435–1441. [Google Scholar] [CrossRef] [PubMed]
  50. Gladwin, M.T.; Lancaster, J.R.; Freeman, B.A.; Schechter, A.N. Nitric oxide’s reactions with hemoglobin: A view through the SNO-storm. Nat. Med. 2003, 9, 496–500. [Google Scholar] [CrossRef]
  51. Stratton, A.; Ericksen, M.; Harris, T.V.; Symmonds, N.; Silverstein, T.P. Mercury(II) binds to both of chymotrypsin’s histidines, causing inhibition followed by irreversible denaturation/aggregation. Protein Sci. 2017, 26, 292–305. [Google Scholar] [CrossRef] [Green Version]
  52. Steck, T.L. The organization of proteins in the human red blood cell membrane. J. Cell Biol. 1974, 62, 1–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Remigante, A.; Morabito, R.; Marino, A. Natural Antioxidants Beneficial Effects on Anion Exchange through Band 3 Protein in Human Erythrocytes. Antioxidants 2019, 9, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Thevenin, B.J.; Willardson, B.M.; Low, P.S. The redox state of cysteines 201 and 317 of the erythrocyte anion exchanger is critical for ankyrin binding. J. Biol. Chem. 1989, 264, 15886–15892. [Google Scholar] [PubMed]
  55. Willardson, B.M.; Thevenin, B.J.; Harrison, M.L.; Kuster, W.M.; Benson, M.D.; Low, P.S. Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J. Biol. Chem. 1989, 264, 15893–15899. [Google Scholar] [PubMed]
  56. Nigra, A.D.; Casale, C.H.; Santander, V.S. Human erythrocytes: Cytoskeleton and its origin. Cell. Mol. Life Sci. 2020, 77, 1681–1694. [Google Scholar] [CrossRef] [PubMed]
  57. Leto, T.L.; Marchesi, V.T. A structural model of human erythrocyte protein 4.1. J. Biol. Chem. 1984, 259, 4603–4608. [Google Scholar]
  58. Satchwell, T.J.; Shoemark, D.K.; Sessions, R.B.; Toye, A.M. Protein 4.2: A complex linker. Blood Cells Mol. Dis. 2009, 42, 201–210. [Google Scholar] [CrossRef]
  59. Galletti, P.; Ki Paik, W.; Kim, S. Methyl acceptors for protein methylase II from human-erythrocyte membrane. Eur. J. Biochem. 1979, 97, 221–227. [Google Scholar] [CrossRef]
  60. Vassalli, Q.A.; Caccavale, F.; Avagnano, S.; Murolo, A.; Guerriero, G.; Fucci, L.; Ausió, J.; Piscopo, M. New insights into protamine-like component organization in Mytilus galloprovincialis sperm chromatin. DNA Cell Biol. 2015, 34, 162–169. [Google Scholar] [CrossRef]
  61. Fioretti, F.M.; Febbraio, F.; Carbone, A.; Branno, M.; Carratore, V.; Fucci, L.; Ausió, J.; Piscopo, M. A sperm nuclear basic protein from the sperm of the marine worm Chaetopterus variopedatus with sequence similarity to the arginine-rich C-termini of chordate protamine-likes. DNA Cell Biol. 2012, 31, 1392–1402. [Google Scholar] [CrossRef] [PubMed]
  62. Piscopo, M.; Trifuoggi, M.; Notariale, R.; Labar, S.; Troisi, J.; Giarra, A.; Rabbito, D.; Puoti, R.; de Benedictis, D.; Brundo, M.V.; et al. Protamine-like proteins’ analysis as an emerging biotechnique for cadmium impact assessment on male mollusk Mytilus galloprovincialis (Lamarck 1819). Acta Biochim. Pol. 2018, 65, 259–267. [Google Scholar] [CrossRef] [PubMed]
  63. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds are not available from the authors.
Figure 1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the cytosolic fraction from mercury (Hg)-treated human red blood cell (RBC). Intact RBC were exposed in vitro for 4 h to different concentrations of mercuric chloride (HgCl2) and the cytosolic fractions analysed by SDS-PAGE. (A) Electrophoretic profile of the cytosolic fractions from untreated RBC (lane 2) and cells exposed to 60, 40, 20, 10 and 1 µM HgCl2 (lanes 3–7, respectively). Molecular weight (MW) markers (lane 1). (B) Densitometric analysis of the 16 and 64 kDa protein bands. The values shown are relative to n = 5 repeats.
Figure 1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the cytosolic fraction from mercury (Hg)-treated human red blood cell (RBC). Intact RBC were exposed in vitro for 4 h to different concentrations of mercuric chloride (HgCl2) and the cytosolic fractions analysed by SDS-PAGE. (A) Electrophoretic profile of the cytosolic fractions from untreated RBC (lane 2) and cells exposed to 60, 40, 20, 10 and 1 µM HgCl2 (lanes 3–7, respectively). Molecular weight (MW) markers (lane 1). (B) Densitometric analysis of the 16 and 64 kDa protein bands. The values shown are relative to n = 5 repeats.
Molecules 25 03278 g001
Figure 2. Acetic Acid Urea-Polyacrylamide Gel Electrophoresis (AU-PAGE) analysis of the cytosolic fraction from Hg-treated human RBC. Intact RBC were exposed in vitro for 4 h to different concentrations of HgCl2 and the cytosolic fraction analysed by AU-PAGE. Samples from untreated RBC (lane 1) and cells exposed to 1, 10 and 60 µM HgCl2 (lanes 2–4, respectively).
Figure 2. Acetic Acid Urea-Polyacrylamide Gel Electrophoresis (AU-PAGE) analysis of the cytosolic fraction from Hg-treated human RBC. Intact RBC were exposed in vitro for 4 h to different concentrations of HgCl2 and the cytosolic fraction analysed by AU-PAGE. Samples from untreated RBC (lane 1) and cells exposed to 1, 10 and 60 µM HgCl2 (lanes 2–4, respectively).
Molecules 25 03278 g002
Figure 3. Effect of Dithiothreitol (DTT) on Hg-induced protein aggregates in human RBC. Intact RBC were treated with for 30 min with 30 mM DTT before and after cell exposure to with 1 µM HgCl2 and the cytosolic fractions analysed by SDS-PAGE. (A) Electrophoretic profile of samples from untreated RBC (lane 1) and from cells exposed to 1 µM HgCl2 (lanes 3–5); MW markers (lane 2); samples from RBC treated with HgCl2 and then with DTT (lane 6); Hb from RBC treated only with DTT (lane 7); Hb from RBC treated with DTT and then with HgCl2 (lane 8). (B) Densitometric analysis of the 16 and 64 kDa protein bands. The values shown are relative to n = 5 repeats.
Figure 3. Effect of Dithiothreitol (DTT) on Hg-induced protein aggregates in human RBC. Intact RBC were treated with for 30 min with 30 mM DTT before and after cell exposure to with 1 µM HgCl2 and the cytosolic fractions analysed by SDS-PAGE. (A) Electrophoretic profile of samples from untreated RBC (lane 1) and from cells exposed to 1 µM HgCl2 (lanes 3–5); MW markers (lane 2); samples from RBC treated with HgCl2 and then with DTT (lane 6); Hb from RBC treated only with DTT (lane 7); Hb from RBC treated with DTT and then with HgCl2 (lane 8). (B) Densitometric analysis of the 16 and 64 kDa protein bands. The values shown are relative to n = 5 repeats.
Molecules 25 03278 g003
Figure 4. SDS-PAGE analysis of the membrane fraction from Hg-treated human RBC. Intact RBC were exposed in vitro for 4 h to 1 µM HgCl2 and the membrane fractions analysed by SDS-PAGE. MW markers (lane 1); sample from untreated (lane 2) and Hg-treated RBC (lane 3).
Figure 4. SDS-PAGE analysis of the membrane fraction from Hg-treated human RBC. Intact RBC were exposed in vitro for 4 h to 1 µM HgCl2 and the membrane fractions analysed by SDS-PAGE. MW markers (lane 1); sample from untreated (lane 2) and Hg-treated RBC (lane 3).
Molecules 25 03278 g004
Figure 5. Effect of HgCl2 treatment on reactive oxygen species (ROS) production in RBC. Intact RBC were exposed in vitro for 4 h to different concentrations of HgCl2 and ROS production was evaluated by means of the fluorescent probe Dichlorofluorescein (DCF). Data are the means ± SEM (n = 9). Statistical analysis was performed with one-way ANOVA followed by Dunnett’s test (* p < 0.05).
Figure 5. Effect of HgCl2 treatment on reactive oxygen species (ROS) production in RBC. Intact RBC were exposed in vitro for 4 h to different concentrations of HgCl2 and ROS production was evaluated by means of the fluorescent probe Dichlorofluorescein (DCF). Data are the means ± SEM (n = 9). Statistical analysis was performed with one-way ANOVA followed by Dunnett’s test (* p < 0.05).
Molecules 25 03278 g005

Share and Cite

MDPI and ACS Style

Piscopo, M.; Notariale, R.; Tortora, F.; Lettieri, G.; Palumbo, G.; Manna, C. Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes. Molecules 2020, 25, 3278. https://doi.org/10.3390/molecules25143278

AMA Style

Piscopo M, Notariale R, Tortora F, Lettieri G, Palumbo G, Manna C. Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes. Molecules. 2020; 25(14):3278. https://doi.org/10.3390/molecules25143278

Chicago/Turabian Style

Piscopo, Marina, Rosaria Notariale, Fabiana Tortora, Gennaro Lettieri, Giancarlo Palumbo, and Caterina Manna. 2020. "Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes" Molecules 25, no. 14: 3278. https://doi.org/10.3390/molecules25143278

Article Metrics

Back to TopTop